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  21 
 Abstract  22 
Epsilon toxin (Etx), a potent pore forming toxin (PFT) produced by Clostridium 23 
perfringens, is responsible for the pathogenesis of enterotoxaemia of ruminants and has 24 
been suggested to play a role in multiple sclerosis in humans. Etx is a member of the 25 
aerolysin family of β-PFTs (aβ-PFTs). While the Etx soluble monomer structure was 26 
solved in 2004, Etx pore structure has remained elusive due to the difficulty of isolating 27 
the pore complex. Here we show the cryo-electron microscopy structure of Etx pore 28 
assembled on the membrane of susceptible cells. The pore structure explains important 29 
mutant phenotypes and suggests that the double β-barrel, a common feature of the aβ-30 
PFTs, may be an important structural element in driving efficient pore formation. These 31 
insights provide the framework for the development of novel therapeutics to prevent 32 
human and animal infections, and are relevant for nano-biotechnology applications. 33 
  34 
 Introduction  35 
Epsilon toxin (Etx) is a pore forming toxin (PFT) produced by Clostridium perfringens 36 
type B and D strains and plays an important role in the pathogenesis of enterotoxaemia, a 37 
severe neurological disease of domestic ruminants, particularly sheep. More recently, Etx 38 
has been implicated in the development of multiple sclerosis (MS) in humans1, 2, 3.  39 
 40 
Etx is typically secreted by the bacterium in the gut as a relatively inactive, water-soluble 41 
monomer, called protoxin (P-Etx), with an estimated molecular weight of 32.9 kDa4. The 42 
protoxin is converted to the active, mature toxin after carboxy- and amino-termini 43 
peptides are removed by proteolytic cleavage in the gut, either by digestive proteases of 44 
the host, such as trypsin, or protease produced by C. perfringens5. Toxin activation 45 
generates a more acidic protein (isoelectric point of 5.4 vs 8.3) that is nearly 1,000 times 46 
more toxic than its progenitor6, 7. By a mechanism unknown, Etx crosses the gut wall, 47 
enters the blood stream and accumulates preferentially in the brain and kidneys8, 9. 48 
 49 
Etx is a member of the aerolysin family of β-pore-forming toxins (aβ-PFTs). Members of 50 
the aβ-PFTs are found in all kingdoms of life and can be used for either attack or 51 
defence10, 11. Other bacterial toxins from the aβ-PFTs that play a role in disease include 52 
aerolysin from the human pathogen Aeromonas hydrophila12, enterotoxin (CPE) from C. 53 
perfringens13, α-toxin from Clostridium septicum14, and monalysin from Pseudomonas 54 
entomophila15. Other members of the aβ-PFTs serve in defence, such as lysenin produced 55 
by immune cells of the earthworm Eisenia fetida16, assist in prey digestion, such as 56 
 hydralysins from Cnidaria17, or have cytocidal activity against human cancer cells, such 57 
as parasporin-2 from Bacillus thuringiensis18.  58 
 59 
As evidenced by their crystal structures, members of the aβ-PFTs share an overall similar 60 
domain arrangement11. They typically contain one or more receptor binding domains 61 
(RBD) and a pore forming module (PFM), a well conserved structural element of the aβ-62 
PFTs11, 19. The PFM, rich in serine and threonine residues, contains a flexible membrane 63 
insertion loop flanked by pre-insertion strands that refold into an amphipathic β-hairpin 64 
during pore formation to create the transmembrane β-barrel of the pore20.  65 
 66 
The crystal structure of the water-soluble, monomeric P-Etx was solved by Cole et al. in 67 
200421 and revealed an elongated molecule composed mainly of β-sheets, with two 68 
strands traversing the entire molecule. The suggested RBD at the amino-terminus 69 
contains a cluster of surface exposed aromatic amino acids critical for cell binding22, 23, 70 
and the PFM at the carboxy-terminus is suggested to play a role in oligomerization and 71 
pore formation11, 19. The PFM also contains a C-terminal peptide (CTP), proteolytic 72 
removal of which is essential for toxin activation6 as interaction of the CTP with the pre-73 
insertion strands restricts their movement, thus preventing pore formation20. A glycan (β-74 
octyl-glucoside) binding site has also recently been identified in the PFM, suggesting that 75 
Etx may have two distinct receptor binding sites22.  76 
 77 
Etx is unique amongst aβ-PFTs as it shows high potency and high cell specificity. The 78 
50% lethal dose (LD50) in mice after intravenous administration of the toxin is reported to 79 
 be 100 ng kg-1 24, equivalent to 7 μg per 70 kg human. This makes Etx the third most 80 
potent clostridial toxin after botulinum and tetanus neurotoxins24. For this reason, the 81 
toxin is classified as a potential biological weapon in some countries and as a category B 82 
biological agent by the U.S. public health body, the Centers for Disease Control and 83 
Prevention (CDC)25. Among the many cell lines tested, only a few are susceptible to Etx. 84 
Most in vitro studies on Etx, including this study, have been carried out using the Madin-85 
Darby Canine Kidney (MDCK) cell line as this cell line is the most sensitive to the 86 
toxin26, 27, 28, 29. The cell specificity of Etx suggests that the toxin binds to a specific 87 
receptor in the membrane of target cells and this is likely to explain why the toxin is over 88 
1,000 times more potent compared to other aβ-PFTs.   89 
 90 
To date, two putative Etx receptors have been identified: the O-linked glycoprotein 91 
hepatitis A virus cellular receptor 1 (HAVCR1)23 and the tetraspan membrane proteolipid 92 
myelin and lymphocyte protein (MAL)2. The molecular basis for the interaction of these 93 
putative receptors with Etx remains unknown, although it is thought that the binding site 94 
for Etx on the glycoprotein HAVCR1 includes one of the sugar components, while in 95 
MAL the second extracellular loop is critical for binding and cytotoxicity of Etx. Etx can 96 
also interact with artificial lipid bilayers and form functional pores without the help of 97 
receptors, albeit with less efficiency30, 31, 32. 98 
 99 
Both inactive P-Etx and activated toxin can bind to cells but only activated toxin with 100 
CTP removed can form heptameric pre-pores on the membrane surface in the next step of 101 
pore formation33. Finally, the heptamer, with a molecular mass of approximately 155-174 102 
 kDa2, 28, 29, 34, inserts into the membrane, which is triggered by significant structural 103 
rearrangements within the PFM of each protomer in the complex. Pore formation disrupts 104 
the membrane and is central to the damage caused to intoxicated cells, and consequently 105 
to the symptoms of disease due to the leakage of water and small ions through the pores 106 
that may lead to cell death.  107 
 108 
Whilst atomic resolution structures of the water-soluble, monomeric forms have been 109 
determined for many members of the aβ-PFTs over the past few decades, their 110 
corresponding pore structures have only recently been revealed. The lysenin pore was the 111 
first high-resolution structure of the aβ-PFTs20, 35. A 3.9 Å structure of the aerolysin pre-112 
pore and a 7.5 Å structure of aerolysin pore have also been determined36.  113 
 114 
The cryo-electron microscopy (cryo-EM) structure of Etx pore determined here provides 115 
further insights into the molecular details of structural rearrangements during the pore 116 
formation process of the aβ-PFTs. These results will have important implications for the 117 
development of novel therapeutics aimed at the functional disruption of pore formation to 118 
prevent human and animal diseases, and are relevant for nano-biotechnology 119 
applications. 120 
  121 
 Results  122 
Isolation of the Etx pore  123 
The formation of biologically active oligomers has been a limiting factor for obtaining 124 
structural information of the pore form of Etx. Unlike aerolysin37, 38, Etx does not 125 
spontaneously oligomerize into SDS-resistant species when activated in aqueous buffer, 126 
and negatively stained EM samples do not reveal regular particles other than elongated 127 
monomers and small clumps (Supplementary Figure 1a). Furthermore, efficient 128 
oligomerization cannot be promoted by the addition of liposomes of various lipid 129 
compositions or detergent micelles. The uncertainty in receptor identity combined with 130 
the high cell specificity of Etx prompted us to investigate if the pores could be assembled 131 
on susceptible cells and then purified for structural studies. We assembled Etx oligomers 132 
that were biologically active towards Super Dome cells, a clone of MDCK cells that 133 
forms domes that are approximately five times the area of MDCK cells, thus exhibiting 134 
exceptional sensitivity to Etx39. The cytotoxic activity of trypsin activated recombinant 135 
wild type Etx towards Super Dome cells was measured using a lactate dehydrogenase 136 
(LDH) assay. The average dose of recombinant Etx required to kill 50% of Super Dome 137 
cells (CT50) was 2.47 ± 0.47 nM (S.E.M.) or 78.27 ± 14.89 ng ml-1 (S.E.M.) (Figure 1a). 138 
Etx monomers oligomerised and formed SDS-resistant pores of an apparent molecular 139 
weight of ∼155 kDa on the membrane of Super Dome cells (Figure 1b), consistent with 140 
previous studies2, 28, 29, 34. Subsequently, the complexes were solubilised in detergent and 141 
treated as single particles for cryo-EM analysis. Solubility screening using 142 
ultracentrifugation identified n-dodecyl-β-D-maltoside (DDM) as a suitable detergent, 143 
 which has previously been successfully used to solubilize lysenin and Etx pores20, 34, 35 144 
(Supplementary Figure 2).  145 
 146 
Structural determination of the Etx pore  147 
When observed using transmission electron microscopy (TEM), the isolated Etx material 148 
appeared heterogeneous. The extremely low yields (∼10 µg from 6 x 108 cells) meant we 149 
could not pursue additional clean-up steps, such as size-exclusion chromatography. This 150 
heterogeneity hindered particle identification and selection using manual or automated 151 
picking procedures (Supplementary Figures 3, 4). Despite this, an initial dataset of 613 152 
micrographs resulted in ∼14,000 particles after 2D and 3D classification clean-up steps 153 
and produced a map which reached 4.6 Å, at which resolution the β-strands just begin to 154 
separate (Supplementary Figure 3, inset). We reasoned that the use of a Volta Phase Plate 155 
(VPP) would be advantageous for two reasons. First, the contrast of the protein 156 
component would increase, aiding particle picking and alignment. Second, the number of 157 
particles required to achieve a high-resolution structure could decrease as compared to 158 
conventional defocused data40. Therefore, we proceeded to image the exact same grid 159 
used before with the VPP. Although the samples still appeared heterogeneous (Figure 160 
2a), approximately two times as many particles remained after clean-up steps as 161 
compared to the non-VPP dataset from a dataset that was only 25% larger. This resulted 162 
in a final map at an overall resolution of 3.2 Å (Figure 2c, d and Supplementary Figure 163 
5). Estimation of the B-factors for both datasets indicated that the phase plate data was 164 
indeed of higher quality when comparing the same number of particles used in a 165 
reconstruction (Supplementary Figure 6). 166 
  167 
Architecture of the Etx pore  168 
The atomic model of the Etx pore is shown in Figure 3a, b. The overall architecture of the 169 
Etx pore resembles that of its structural homologues lysenin20, 35 and aerolysin36, with a 170 
β-barrel that spans the height of the molecule, a motif that so far seems specific for the 171 
aβ-PFTs. The Etx pore also lacks a vestibule that is found in the α-hemolysin family of β-172 
PFTs where the β-barrel begins close to the membrane spanning region (Supplementary 173 
Figure 7a, d, respectively). The Etx assembly measures ~120 Å across and ~98 Å in 174 
height. The lumen of the β-barrel measures ~24 Å (Cα-Cα) at its widest, although local 175 
restrictions are present (see below).  176 
 177 
Each protomer in the pore structure can be divided into three domains (Figure 3a, b): the 178 
β-hairpin domain (blue), the cap domain (yellow) and the receptor binding domain 179 
(green). The β-hairpin domain (residues 95-173) creates the inner β-barrel, which begins 180 
at the top of the pore and runs through the entire length of the assembly, including the 181 
membrane-spanning region. The cap domain (residues 63-94, 174-198 and 235-260) at 182 
the extracellular side, also referred to as the collar35, includes an outer β-barrel that 183 
surrounds the membrane-distal region of the inner β-barrel, and thus contributes to the 184 
highly conserved, concentric double β-barrel (DBB) fold, a common feature of the aβ-185 
PFTs41. The receptor binding domain (residues 1-62 and 199-234) is unique to each β-186 
PFT and determines the binding specificity of the toxin.   187 
 188 
The β-hairpin domain  189 
 As has been shown previously20, members of the aβ-PFTs form β-barrels that span the 190 
height of their pores. This domain includes the insertion loops that have been 191 
hypothesized to form the membrane spanning regions (Etx residues 123-148)21, 42, 43. As 192 
in lysenin, in fact the β-barrel recruits polypeptide from the flanking β-strands on either 193 
side of the insertion loop so that the β-hairpin domain actually comprises residues 95-194 
173. The lumen of the pore is mostly lined with serine and threonine residues, yet another 195 
characteristic of the aerolysin family, but asparagine and glutamine residues are also 196 
present. Additionally, a number of salt bridges are present (Supplementary Figure 8c-e). 197 
Forming intra-chain bridges are Lys99-Asp168 and Lys108-Glu159. Lys130 with Glu137 198 
form an inter-chain salt bridge which stabilizes the β-barrel near the intracellular side of 199 
the pore in addition to the hydrogen bonding network. The overall charge distribution in 200 
the lumen is therefore neutral (Supplementary Figure 9b). At its narrowest point the 201 
diameter of the lumen is constricted to ~12 Å by the seven Lys108 residues which 202 
protrude into the lumen (Supplementary Figure 8a and Supplementary Figure 9b, 203 
rectangle). The structure corroborates studies that show Etx has only a slight preference 204 
for anions31, 32. The β-turn at the intracellular side is formed by Thr132, Val133, Pro134 205 
and Phe135. Aerolysin and Etx are conserved in this region. Pro134 is equivalent to 206 
Pro248 in aerolysin and, as in aerolysin, the β-turn main chain protrudes sideways, 207 
forming a rivet to anchor the barrel at the intracellular side (Figure 3c)44. 208 
 209 
The external surface of the Etx inner β-barrel reveals a number of interesting features 210 
(Figure 3c). In the intracellular side of the membrane two aromatic residues, Phe131 and 211 
Phe135, form the usual aromatic belt found in β-barrel transmembrane regions. However, 212 
 in the extracellular side of the membrane there are two aromatic belts. One is formed by 213 
Tyr146 ~30 Å from the tip, and the other formed by His119 (H106 in Etx without 214 
propeptide45) and Phe148 ~35 Å from the tip.  215 
 216 
Examination of the unfiltered maps indicates that the detergent micelle density extends 217 
above His119 and Phe148, suggesting these residues will be interacting with the 218 
membrane (Supplementary Figure 10). Therefore, we propose that the membrane-219 
inserted region in the Etx pore comprises residues 119-148, close to the original 220 
prediction21. Interestingly, histidine residues were also found in the detergent micelle 221 
region of lysenin above the standard aromatic belt20. Towards the membrane-distal part 222 
of the inner β-barrel, His162 (H149 in Etx without propeptide) is another important 223 
residue for Etx activity22, 45. H162 (Nδ1) is within hydrogen bonding distance of D250 224 
(Oδ2) which lies in the cap domain of the same chain (Figure 3d and Supplementary 225 
Figure 8a). 226 
 227 
The receptor binding domain (RBD)  228 
This region undergoes minimal conformational changes in the transition from the water-229 
soluble form, as in lysenin20. Unique to Etx, and unlike lysenin and aerolysin, the 230 
individual RBDs are well separated and do not interact with their neighbours (Figure 3b, 231 
Supplementary Figure 7a-c), and thus do not contribute to any oligomerization surfaces. 232 
The lack of physical constraints in the RBD could infer higher flexibility in receptor 233 
selection and binding, and in part explains why the resolution of this domain is lower 234 
than that of the other domains (Supplementary Figure 5). Overall, the RBD in the 235 
 oligomer overlaps well with the corresponding region of the crystal structure of Etx in its 236 
monomeric form (PDB ID: 1UYJ) (Supplementary Figure 11), with an RMSD of 1.7 Å 237 
(Cα- Cα). A number of tyrosine residues (Tyr 42, 43, 49 and 209; corresponding to Tyr 238 
29, 30, 36 and 196 in22, 46) which were identified in earlier studies as important in 239 
receptor binding22, 46 are located directly above the membrane in a position that would 240 
facilitate interaction with a receptor (Figure 3c). As shown in Supplementary Figure 9a, 241 
d, the tips of the RBD are predominantly hydrophobic. 242 
 243 
The cap domain  244 
The cap domain links the RBD to the β-hairpin domain and undergoes significant 245 
rearrangement in the pore form, as discussed below. In the pore conformation it 246 
contributes the outer β-barrel to the DBB fold (Figure 3d). In aerolysin, the DBB fold has 247 
been shown to be responsible for the SDS-resistant character of aerolysin36. In Etx the 248 
DBB fold is stabilised by hydrophobic interactions between the inner and outer β-barrel 249 
that includes valines, leucines, isoleucines, offset π-π stacking between Tyr84 and 250 
Phe105 residues, as well as some hydrogen bonds, including H162 and D250 mentioned 251 
above (Figure 3d and Supplementary Figure 8a, b). 252 
 253 
To investigate the importance of the H162-D250 interaction, we constructed D250A and 254 
H162A mutants. Etx-H162A (corresponding to H149A in45) has previously been reported 255 
to have reduced, but not abolished, toxicity45, and the crystal structure of P-Etx-H162A 256 
closely resembles that of wild type P-Etx22, while purified recombinant Etx-D250A is 257 
completely inactive towards Super Dome cells, as shown in Supplementary Figure 12a, 258 
 and thermal stability assays indicate that P-Etx-D250A behaves similarly to wild type P-259 
Etx (Supplementary Figure 12b), suggesting that P-Etx-D250A is correctly folded. 260 
Examination of D250 and H162 in the monomeric Etx crystal structure indicates that 261 
D250 and H162 are not involved in any interactions, suggesting that the importance of 262 
these residues lies in the H162-D250 hydrogen bond formed in the oligomer. SDS-PAGE 263 
analysis of oligomer formation revealed that both Etx-D250A and Etx-H162A produce 264 
SDS-resistant oligomers of the same apparent molecular weight as wild type Etx (∼155 265 
kDa, consistent with previous reports2, 28, 29, 34) (Supplementary Figure 13). When Super 266 
Dome cells were incubated with activated wild type Etx, Etx-D250A or Etx-H162A 267 
(Supplementary Figure 13a, lanes 11-13), oligomers were formed with a mean oligomer 268 
yield of 5.09 ± 2.62% (S.E.M.) for Etx-D250A (Supplementary Figure 13b), albeit in a 269 
concentration dependent manner (Supplementary Figure 14), and with a mean oligomer 270 
yield of 44.54 ± 10.25% (S.E.M.) for Etx-H162A relative to wild type Etx 271 
(Supplementary Figure 13b). These results suggest that while D250A oligomers 272 
resembling the wild type ones, either in a pre-pore or post pre-pore state, can assemble, 273 
they cannot produce pores that have a cytotoxic effect on cells (Supplementary Figure 274 
12a), even at the highest concentration of 6 µM tested (2,426 times the CT50 dose of wild 275 
type Etx). Further analysis of oligomer formation by native-PAGE revealed a much 276 
larger complex of ∼624 kDa relative to the SDS-resistant oligomers of ∼155 kDa when 277 
Super Dome cells were incubated with activated wild type Etx (Supplementary Figure 15, 278 
lane 10). The same complex, albeit at lower intensity, was also observed when cells were 279 
incubated with activated Etx-H162A (Supplementary Figure 15, lane 12), but was not 280 
detectable when cells were incubated with activated Etx-D250A (Supplementary Figure 281 
 15, lane 11), providing further evidence that D250A oligomers detected by SDS-PAGE 282 
may not correspond to pores. Both D250A and H162A mutants retain their ability to bind 283 
to Super Dome cells (Supplementary Figure 13a, lanes 8-10, and Supplementary Figure 284 
15a, lanes 7-9), suggesting that residues D250 and H162 are important for events 285 
downstream of receptor binding. Similar to activated wild type Etx, negative stain EM 286 
did not reveal regular particles other than elongated monomers and small clumps for 287 
activated Etx-D250A and Etx-H162A (Supplementary Figure 1).  288 
 289 
Structural rearrangements during pore formation  290 
Comparison of the crystal structure of Etx monomer to its membrane-inserted form 291 
illustrates the large conformational changes that occur upon pore formation (Figure 4 and 292 
Supplementary Movie 1). The cap domain moves downward towards the membrane by 293 
45 Å creating a kink in the straight cap domain. In turn, the β-hairpin domain, consisting 294 
of the hypothetical insertion loop and the pre-insertion strands, as for lysenin20, unfolds to 295 
create the inner β-barrel that spans the entire length of the Etx pore. In contrast to lysenin, 296 
the cap domain in Etx moves slightly away from the inner β-barrel rather than towards it. 297 
 298 
To further understand how Etx assembles into an oligomer and the rearrangements 299 
required for transition to the pore state, we constructed a hypothetical pre-pore by 300 
superimposing the crystal structure monomer to the RBD of the pore structure and 301 
imposing 7-fold symmetry, similar to hypothetical pre-pores constructed previously for 302 
lysenin20, 35. This allowed us to observe some of the displacements that have to occur 303 
prior to pre-pore formation (Supplementary Figure 16). Calculations of molecular clashes 304 
 (inter-atom overlap >0.6 Å) highlight the potential regions that would have to rearrange 305 
upon oligomerisation. It is clear from these clashes that the CTP, as expected, severely 306 
obstructs oligomerization, and the pre-pore model illustrates why this region must be 307 
removed prior to monomer association. In addition to the CTP, other significant clashes 308 
occur near the oligomerisation surfaces on either side of a monomer, indicating again that 309 
some rearrangement will have to happen. Finally, the hypothetical insertion loop or 310 
tongue also creates clashes upon monomer association and, as described previously for 311 
lysenin35, the displacement of the tongue region may be the driving force for the pre-312 
insertion strands to unfold and the formation of the inner β-barrel. 313 
  314 
 Discussion 315 
The pore form of Etx has long eluded structural determination, mostly owing to the 316 
difficulty of forming biologically active Etx oligomers in liposomes of various lipid 317 
compositions or detergent micelles without a receptor, which is unknown. Thus, the only 318 
viable way to study the pore form of Etx was to isolate the complexes directly from cells 319 
known to be susceptible to Etx. In this study, the use of Super Dome cells, reported to 320 
have 3 to 78-fold increased sensitivity to Etx relative to MDCK cells39, combined with 321 
the use of increased concentration of DDM (2% (w/v)) relative to 0.05% (w/v) used in34 322 
maximized pore yield for subsequent purification, and thus were critical for structural 323 
determination of the Etx pore complex. Furthermore, due to the very small quantities of 324 
material that can be isolated from the membrane of cultured cells and the heterogeneity of 325 
the purified samples, cryo-EM technique was the only structural method that could be 326 
employed. Use of the VPP proved essential in our studies to achieve high resolution, 327 
owing to the challenging sample rather than its molecular mass (∼225 kDa). First, 328 
particles could be identified by the automatic and manual picking procedures more 329 
efficiently, resulting in more particles (Supplementary Figure 4). Second, the overall 330 
quality of the data, as judged by B-factor estimation from both datasets, was higher for 331 
the VPP data, meaning we could achieve higher resolution than with the non-VPP data, 332 
given the number of particles (Supplementary Figure 6). While this manuscript was under 333 
review, another cryo-EM study of a relatively large complex (~500 kDa) also benefited 334 
by the use of the VPP47, suggesting that VPP use could be advantageous for certain 335 
specimens which are not size limited. The resulting map at 3.2 Å resolution allowed an 336 
unambiguous model to be built for Etx pore. 337 
  338 
A number of interesting mutants of Etx have been studied in the past whilst trying to 339 
understand how Etx transitions from the water-soluble to the pore form. Mutating H149 340 
(H162 in our model) to alanine resulted in a significant decrease in activity of the 341 
recombinant toxin both in vitro and in vivo45. However, substitution with serine at 342 
position 162 does not abolish lethal activity45, suggesting that H162A is less active not 343 
because of removal of the bulky imidazole side chain but possibly due to the loss of a 344 
hydrogen bond donor at this position. H162, located in the membrane-distal part of the 345 
inner β-barrel, has previously been equated to aerolysin Y221 and recent studies 346 
proposed that, similar to the aerolysin Y221G mutant, the Etx H162A mutant may 347 
prevent the β-hairpin domain involved in pore formation from unfolding19, 41. However, 348 
unlike the aerolysin Y221G mutant, the Etx H162A mutant did not reveal water-soluble, 349 
heptameric pre-pore particles by negative stain EM (Supplementary Figure 1b). 350 
 351 
Examination of the Etx pore structure reveals that H162 may also play a role in 352 
stabilizing the DBB fold by forming a hydrogen bond with D250 in the cap domain. This 353 
interaction will stabilize the DBB fold further in addition to the hydrophobic interactions 354 
and make it more rigid. In agreement with this hypothesis, substitution of aspartate with 355 
alanine at position 250 results in a completely inactive Etx that displays ∼95% reduction 356 
in SDS-resistant oligomers relative to wild type Etx. The reduced oligomerization of Etx-357 
D250A and its complete inactivity towards Super Dome cells could be a result of either 358 
oligomer instability or a reduction in oligomer formation. Since D250 does not 359 
participate in any inter-chain interactions in the oligomer we cannot explain the latter. 360 
 The abolished cytotoxicity of Etx-D250A suggests that the SDS-resistant oligomers 361 
resembling the wild type ones may correspond to pre-pores or post pre-pores. This may 362 
explain why Etx-D250A oligomers resembling the wild type ones were not observed by 363 
native-PAGE immunoblot. Pre-pores or post pre-pores are expected to migrate differently 364 
to pores on native-PAGE as they will lack any associated detergents or lipids. 365 
 366 
Further evidence for the importance of the DBB stability in pore formation also comes 367 
from previous mutagenesis studies. Tyrosine 84 in the cap domain and F105 in the inner 368 
β-barrel have previously been identified as important to Etx function48. Y84A completely 369 
abolishes pore formation and is only recoverable by substitution to another aromatic 370 
residue, whilst F105A has reduced cytotoxic activity towards MDCK cells at low toxin 371 
concentrations48. In the pore structure these two residues form a π-π stacking interaction 372 
(Figure 3d and Supplementary Figure 8b). Similar to D250A and H162A mutants, Y84A 373 
and F105A mutants also retain their ability to bind to MDCK cells. 374 
 375 
Based on previous studies and the pore structure presented here, we propose that the 376 
stability of the DBB fold may be important in coupling the conformational changes that 377 
occur in the cap domain (the vertical collapse by 45 Å) to the insertion of the inner β-378 
barrel into the membrane. By stabilizing the top end of the inner β-barrel as it is being 379 
formed by the unfolding of the β-hairpin domain, the insertion into the membrane will be 380 
analogous to a drill which is forced into the ground by applying force at the top. 381 
Similarly, the RBDs with their hydrophobic tips may keep the complex anchored to the 382 
membrane during membrane insertion, analogous to the stabilizing feet of the drill, by 383 
 either an interaction with the receptor or with the lipid bilayer itself. The pre-pore 384 
structure of aerolysin by cryo-EM36 showed that the DBB has already formed at this stage 385 
and is a pre-requisite to insertion of the inner β-barrel into the membrane. 386 
 387 
Monomeric P-Etx has previously been crystallized bound to β-OG in the PFM of the 388 
carboxy-terminus22. In the pore form of Etx the β-OG binding site is disrupted and the 389 
interacting residues (V85, F105 and T106, corresponding to V72, F92 and T93 in22) are 390 
scattered amongst the inner β-barrel and the cap domain. Similar to aerolysin49, in order 391 
for Etx to cross the thick layer of glycocalyx covering the apical side of gut epithelial 392 
cells, Etx may initially bind to surface oligosaccharides with low affinity, possibly 393 
through the β-OG binding site at the carboxy-terminus, before being progressively 394 
shuttled towards the membrane surface where it would bind with high affinity to its 395 
receptor through the RBD at the amino-terminus. This hypothesis is supported by the 396 
finding that polarized epithelial cells are more sensitive to Etx from their apical side, 397 
which is more abundant in oligosaccharides, than from their basolateral side29, 50. Binding 398 
of Etx to a double receptor in the nervous system has also been suggested previously9.   399 
 400 
The knowledge of conformational rearrangements and protomer interfaces established 401 
upon pore formation can be applied to a traditional structure-based drug discovery 402 
approach, in which high-affinity small compounds are identified that target structural 403 
features to block pore formation, and thus impair bacterial virulence. Further studies on 404 
Etx will have important implications for the development of novel therapeutics aimed at 405 
 the functional disruption of pore formation to prevent human and animal infections, and 406 
are relevant for nano-biotechnology applications.  407 
  408 
 Methods 409 
Materials  410 
Chemicals were purchased from Sigma, UK, unless otherwise stated. The polyclonal 411 
antibody against Etx mutant Y30A-Y196A was raised in rabbits as described in51. After 412 
electrophoretic separation purified Etx pore was visualised by SimplyBlue staining 413 
(Invitrogen Ltd., Paisley, UK). Protein concentrations were determined using the 414 
Pierce™ BCA Protein Assay Kit (Fisher Scientific Ltd., Loughborough, UK). Synthetic 415 
oligonucleotides were sourced from Eurofins Genomics, Germany.  416 
 417 
Recombinant protein production and purification  418 
The gene, etxB, encoding epsilon protoxin (P-Etx) was PCR amplified using synthetic 419 
oligonucleotides Etx-NcoI-F and Etx-XhoI-R (Supplementary Table 1) designed to bear 420 
restriction enzyme sites NcoI and XhoI, respectively, to facilitate directional cloning into 421 
the expression vector pHis-Parallel1 (GenBank: AF097413.1). This fused the amino-422 
terminal end of P-Etx without the 14 amino-terminal residues (KEISNTVSNEMSKK) to 423 
the 26 amino acid residue long peptide (MSYYHHHHHHDYDIPTTENLYFQGAM), 424 
which contains an amino-terminal polyhistidine (6 x His) affinity tag upstream of a 425 
spacer region (DYDIPTT) and the rTEV protease cleavage site (ENLYFQG). The fidelity 426 
of PCR amplification was verified by automated DNA sequencing (Eurofins Genomics, 427 
Germany). The recombinant plasmid expressing P-Etx is termed pHis-Parallel1-P-Etx. 428 
Amino acid numbering corresponds to P-Etx with the 13 amino acids amino-terminal 429 
peptide sequence, unless otherwise stated. 430 
 431 
 For expression of P-Etx, recombinant plasmid pHis-Parallel1-P-Etx was transformed into 432 
E. coli Rosetta 2 (DE3) cells (Merck, Darmstadt, Germany) and expression of P-Etx was 433 
induced using the autoinduction system as described before22 but with modifications. In 434 
brief, cells (100 ml) were grown at ACDP/ACGM containment level 3 in ZYM-5052 435 
autoinducing medium supplemented with 50 μg ml-1 carbenicillin and 34 μg ml-1 436 
chloramphenicol and cultured at 37 ˚C for 3 h at 300 rpm, then for a further 24 h at 20 ˚C, 437 
300 rpm.  Cells were harvested by centrifugation at 10,000 g for 10 min at 4 °C and the 438 
cell pellet was lysed  by 10 ml BugBuster™ Protein Extraction Reagent (Merck, 439 
Darmstadt, Germany) containing rlysozyme™ (0.5 µl at 30 KU µl-1) (Merck, Darmstadt, 440 
Germany) and Benzonase® Nuclease (10 µl at 25 U µl-1) (Merck, Darmstadt, Germany). 441 
The cell suspension was incubated on a rotating mixer for 25 min at room temperature 442 
and centrifuged at 16,000 g for 20 min at 4 °C to separate soluble and insoluble fractions. 443 
The supernatant was loaded onto His GraviTrap columns (GE Healthcare Life Sciences, 444 
Little Chalfont, UK) following the manufacturer’s guidelines. In brief, His-tagged P-Etx 445 
was bound to the affinity column using a buffer composed of 20 mM sodium phosphate, 446 
500 mM NaCl, 20 mM imidazole, pH 7.4. The column was washed with a buffer 447 
composed of 20 mM sodium phosphate, 500 mM NaCl, 60 mM imidazole, pH 7.4. 448 
Recombinant P-Etx was eluted in a buffer composed of 20 mM sodium phosphate, 500 449 
mM NaCl, 500 mM imidazole, pH 7.4. All purification steps were carried out at 4 °C. For 450 
buffer exchange and sample clean-up, P-Etx-containing eluate was applied to a PD-10 451 
Desalting Column (GE Healthcare Life Sciences, Little Chalfont, UK) and eluted in 452 
Dulbecco's phosphate-buffered saline (DPBS) pH 7.0 - 7.2 (Invitrogen). Protein 453 
concentrations were determined by BCA assay.  454 
  455 
Activation of P-Etx by trypsin  456 
Purified recombinant P-Etx was activated with trypsin, TPCK treated from bovine 457 
pancreas, which removes the carboxy-terminal peptide (CTP) sequence. Trypsin was 458 
prepared in DPBS and added to recombinant P-Etx at 1:100 (w/w) ratio and incubated at 459 
room temperature for 1 h. The reaction was stopped by adding trypsin inhibitor (0.66 mg 460 
per 1 mg trypsin) to the digest. Removal of the CTP sequence was assessed by SDS-461 
polyacrylamide gel electrophoresis (PAGE). 462 
 463 
Site directed mutagenesis  464 
Mutation D250A or H162A was introduced into wild type recombinant Etx using primer 465 
pairs D250A-F and D250A-R or H162A-F and H162A-R, respectively (Supplementary 466 
Table 1) and the QuickChange Lightning Site-Directed Mutagenesis Kit (Agilent 467 
Technologies, Inc. Santa Clara, US) according to the manufacturer’s instructions. The 468 
presence of the intended mutation was verified by automated DNA sequencing (Eurofins 469 
Genomics, Germany). 470 
 471 
Thermostability assay  472 
Thermostability of purified recombinant P-Etx-D250A was assessed by mixing purified 473 
protein (0.25 mg ml-1) with 240x SYPRO Orange protein gel stain. Fluorescence was 474 
monitored using a QuantStudio™ 6 Real-Time PCR System (Applied Biosystems, USA) 475 
with a 1% thermal gradient from 25 °C to 99 °C. The fluorescence data obtained was 476 
 analysed using the Protein Thermal Shift Software (Applied Biosystems, USA) to 477 
calculate the melting temperature (Tm) using the Boltzmann method.  478 
 479 
Cell culture  480 
Super Dome (ATCC® CRL-2286™; American Type Culture Collection (ATCC), USA) 481 
cells, a canine epithelial-like cell line established by cloning from the MDCK (ATCC® 482 
CCL-34™) cell line, were routinely cultured in Dulbecco's Modified Eagle’s Medium / 483 
Ham's F-12 medium (DMEM/F-12, HEPES; Life Technologies) with 2.5 mM L-484 
glutamine, 15 mM HEPES, 0.5 mM sodium pyruvate and 1.2 g l-1 sodium bicarbonate 485 
supplemented with 0.05 mM nonessential amino acids and 10% Foetal Bovine Serum 486 
Gold (PAA, Pasching, Austria) at 37 °C in a humidified atmosphere of 95% air/5% CO2. 487 
The culture medium was replaced every 2 to 3 days. Cells were routinely detached by 488 
incubation in trypsin/EDTA and split as appropriate (typically 1:5 dilutions). For dome 489 
formation, Super Dome cells were fed twice a day by a complete medium change. 490 
 491 
Cytotoxicity assay  492 
The cytotoxic activity of trypsin-activated Etx toward Super Dome cells was determined 493 
by measuring the amount of LDH released from the cytosol of lysed cells into the cell 494 
culture medium using the CytoTox 96 nonradioactive cytotoxicity assay kit (Promega, 495 
Southampton, UK) according to the manufacturer’s protocol. In brief, a two-fold dilution 496 
series of each activated toxin (ranging from 139 nM to 0.067 nM) was prepared in DPBS 497 
and added to cells seeded into 96-well plates (3 x 104 cells per well). Following 498 
incubation at 37 °C for 3 h, cell culture medium (50 µl) was harvested from cell 499 
 monolayers, transferred to a fresh 96-well enzymatic assay plate and 50 µl of 500 
reconstituted substrate mix was added to each well. The plate was incubated for 30 min at 501 
room temperature, protected from light. Absorbance was measured at 490 nm using a 502 
Tecan Infinite 200 PRO Microplate Reader (Tecan Group Ltd., Switzerland). The 503 
absorbance values for each sample were normalized by subtracting the absorbance value 504 
obtained for the culture medium from untreated cells. The toxin dose required to kill 50% 505 
of the cell monolayer (CT50) was determined by nonlinear regression analysis, fitting a 506 
variable slope log(dose) versus response curve, constraining F to a value of 50 (logCT50 = 507 
logCTF - (1/HillSlope)*log(F/(100-F)).  508 
 509 
Epsilon toxin pore assembly  510 
Super Dome cells were grown to confluency in 30 times T175 flasks. Each flask of cells 511 
was incubated with 5 ml cell culture medium containing trypsin-activated Etx (25 µg ml-512 
1; 50 times the average minimum dose required to lyse 100% cells) at 37 °C for 1 h to 513 
allow binding and pore formation. Lysed cells were centrifuged at 1,500 g for 15 min at 4 514 
°C to pellet cellular debris and unbound Etx was removed by ultracentrifugation at 515 
100,000 g for 1 h at 4 °C using a Beckman Type 70Ti rotor. Solubilisation of toxin 516 
complex from Super Dome cells was carried out by resuspending the pellet in DPBS (pH 517 
7.0 – 7.2) containing 137 mM NaCl and 2% (w/v) n-dodecyl-β-D-maltoside (DDM) and 518 
incubation at 4 °C overnight, a modification of the method described by Shimada et al.34 519 
where the toxin complex from MDCK cells was solubilized by resuspending the pellet in 520 
20 mM sodium phosphate buffer (pH 7.4) containing 0.05% (w/v) DDM and incubation 521 
at 25 °C for 1 h. After incubation, insoluble material was removed by ultracentrifugation 522 
 at 75,000 g for 45 min at 10 °C using a Beckman Type 70Ti rotor. Solubilised Etx 523 
oligomers were bound to Ni-NTA Agarose resin (Qiagen), washed with two times 20 524 
volumes of DPBS, 0.02% (w/v) DDM, and eluted in three volumes of DPBS, 200 mM 525 
imidazole, 0.02% (w/v) DDM. 526 
 527 
Detergent screening  528 
To screen for a suitable detergent that could efficiently extract and maintain Etx pores 529 
soluble, Super Dome cell membrane was incubated with trypsin-activated Etx for 1 h at 530 
37 °C and membrane incubations were distributed between nine tubes. After 531 
ultracentrifugation at 100,000 g for 1 h at 4 °C using a TLA 120.1 rotor, each pellet was 532 
resuspended in DPBS containing 137 mM NaCl and detergent (1% (w/v) DDM, 1% 533 
(w/v) DM, 0.5% (w/v) C12E8, 1% (w/v) FC-12, 2% (w/v) β-OG, 2% (w/v) C8E4, 1% 534 
(w/v) CYMAL-5, 1% (w/v) LDAO or 1% (w/v) LMNG) and incubated overnight at 4 °C 535 
with occasional shaking. After incubation, 10 µl aliquots were removed from each tube 536 
for Western blot analysis (total protein in detergent) and insoluble material was removed 537 
by ultracentrifugation, as before. The supernatants, which contained solubilised Etx pore, 538 
were collected and 10 µl aliquots were removed from each tube to assess Etx pore 539 
solubilisation by Western blot analysis using 6×-His Tag Monoclonal Antibody 540 
(4A12E4) (Invitrogen, Paisley, UK; catalogue number 37-2900) and IRDye® 800CW 541 
Goat (polyclonal) Anti-Mouse IgG (H+L), Highly Cross Adsorbed secondary antibody 542 
(LI-COR Biosciences, Lincoln, USA; catalogue number 926-32210) at 1:500 and 1:5,000 543 
dilutions, respectively. The solubilization yields for each detergent were determined by 544 
 calculating the % of Etx pore in the supernatant relative to its amount in the total protein 545 
sample using Image Studio ver 5.2 software (LI-COR Biosciences, Lincoln, USA). 546 
 547 
Epsilon pore purification  548 
For DDM-extracted samples, solubilised Etx oligomers were bound to Ni-NTA resin 549 
(Qiagen), washed with 20 volumes of DPBS containing 20 mM imidazole and 0.02% 550 
(w/v) DDM, transferred to a BioRad gravity-flow column, washed again with 20 volumes 551 
of DPBS containing 20 mM imidazole and 0.02% (w/v) DDM, and eluted in three 552 
volumes of DPBS containing 200 mM imidazole and 0.02% (w/v) DDM. 553 
 554 
Binding and oligomerization  555 
Super Dome cells were grown to confluence in 6-well plates (1.2 x 106 cells per well) and 556 
after washing cells three times with DPBS to remove residual trypsin, each well was 557 
incubated with 2 ml pre-warmed DMEM-F12 medium containing trypsin-activated 558 
recombinant Etx wild type, Etx-D250A or Etx-H162A (391 ng ml-1, equivalent to 5x 559 
CT50 dose of wild type Etx) at 37 °C for 1 h to allow binding and/or oligomerisation. 560 
Cells were subsequently washed three times with DPBS to remove unbound Etx, lysed by 561 
three cycles of freezing and thawing in 100 µl DPBS supplemented with Halt™ Protease 562 
Inhibitor Cocktail (100×) (Thermo Fisher Scientific, UK) at a final concentration of 1x, 563 
and harvested by scraping.  The collected cells were transferred to a microcentrifuge tube 564 
and solubilized in DPBS containing 1% (w/v) DDM by incubation at 4 °C overnight with 565 
occasional shaking. After incubation, insoluble material was removed by centrifugation at 566 
 20,000 g for 30 min at 4 °C and the concentration of solubilised protein was determined 567 
by BCA assay.  568 
 569 
Toxin complexes or monomers in solubilisation buffer were analysed by native-PAGE 570 
and SDS-PAGE. Solubilized proteins were resolved by NuPAGE™ 7% Tris-Acetate 571 
Protein Gels (Invitrogen Ltd., Paisley, UK) using Surelock Xcell apparatus (Invitrogen 572 
Ltd., Paisley, UK). For protein gel electrophoresis under denaturing running conditions 573 
NuPAGE™ Tris-Acetate SDS Running Buffer (Invitrogen Ltd., Paisley, UK) and 574 
NuPAGE LDS sample buffer (Invitrogen Ltd., Paisley, UK) were used. For protein gel 575 
electrophoresis under native running conditions Novex™ Tris-Glycine Native Running 576 
Buffer (Invitrogen Ltd., Paisley, UK) and Novex™ Tris-Glycine Native Sample Buffer 577 
(Invitrogen Ltd., Paisley, UK) were used. Denaturing gels were electrophoresed at 150 V 578 
for 1 h at room temperature, while native gels were electrophoresed at 150V for 2 h in ice 579 
cold running buffer. For SDS-PAGE the molecular weight standard Perfect Protein™ 580 
Marker, 10 to 225 kDa (Merck, Darmstadt, Germany) was used. For native-PAGE the 581 
molecular weight marker NativeMark™ Unstained Protein Standard (Invitrogen Ltd., 582 
Paisley, UK) was used. 583 
 584 
After electrophoresis, proteins in the gel were transferred to a nitrocellulose membrane 585 
using the Trans-Blot® Turbo™ Transfer System (Bio-Rad). The membrane was blocked 586 
with PBS containing 0.1% Tween-20 and 5% skim milk and bound P-Etx and/or 587 
oligomeric complexes were detected with rabbit anti-Etx polyclonal primary antibody51 at 588 
1:500 dilution and IRDye® 800CW goat anti-rabbit IgG (H + L) secondary antibody (LI-589 
 COR Biosciences, Lincoln, USA; catalogue number 926-32211) at 1:5,000 dilution. For 590 
loading control the mouse monoclonal Na+/K+-ATPase α1 (C464.6): sc-21712 primary 591 
antibody (Santa Cruz Biotechnology; catalogue number sc-21712) and the IRDye® 592 
680RD goat (polyclonal) anti-mouse IgG (H+L) secondary antibody (LI-COR 593 
Biosciences, Lincoln, USA; catalogue number 925-68070) were used at 1:200 and 594 
1:5,000 dilutions, respectively. Antibodies were diluted in PBS containing 0.1% Tween-595 
20 and 3% skim milk. Immuno-reactive bands were detected using the Odyssey CLx 596 
infrared imaging system (LI-COR Biosciences, Lincoln, USA). Quantitative analyses 597 
were performed using the Image Studio ver 5.2 software and the Housekeeping Protein 598 
Normalization Protocol (LI-COR Biosciences, Lincoln, USA). The oligomer yield for 599 
each Etx variant was determined by calculating the percentage of fluorescence intensity 600 
relative to wild type toxin. 601 
 602 
Negative stain electron microscopy  603 
Purified recombinant P-Etx variants were trypsin-activated as described above. After 604 
activation, samples were diluted to 0.02 mg ml-1 and 3 μl was added to freshly glow-605 
discharged carbon-coated grids for 60 seconds before staining with 20 μl of 2% (w/v) 606 
aqueous uranyl acetate. Grids were then imaged on a Philips CM200 FEG transmission 607 
electron microscope operating at an accelerating voltage of 200 kV. Images were 608 
recorded at a calibrated pixel size of 2 Å on a TVIPS F224HD CCD camera. 609 
 610 
Specimen preparation and data collection  611 
 Etx eluate fraction 4 (approximately 0.04 mg ml-1) was diluted three-fold in elution buffer 612 
(DPBS containing 20 mM imidazole and 0.02% (w/v) DDM) and deposited on Quantifoil 613 
R1.2/1.3 grids overlaid with graphene oxide, as described in20. Grids were then blotted 614 
and plunge-frozen using a custom-made device and stored in LN2 until further use. Data 615 
was collected on a FEI Titan Krios operating at an accelerating voltage of 300 kV. All 616 
datasets were collected on a FEI Falcon 3EC direct electron detector at a nominal 617 
magnification of 75K× (calibrated pixel size of 1.07 Å) and a dose rate of 0.6e- per pixel 618 
per second in counting mode over 60 seconds and 75 fractions. Conventionally defocused 619 
and phase plate datasets were collected using the EPU software (Thermo-Fisher 620 
Scientific). In brief, grid squares and suitable holes were selected and microscope 621 
alignments were performed. Just prior to data collection, the phase plate was inserted and 622 
the un-scattered beam was made parallel by observing the Ronchigram in the back focal 623 
plane of the objective lens over an empty specimen area. Condenser astigmatism was 624 
corrected by reducing the smearing of the Ronchigram near the blow-up point. Due to the 625 
extremely low screen current used (~0.014 nA), the 150 μm C2 aperture was used to aid 626 
in this process and then switched back to the 50 μm aperture. Coma and astigmatism 627 
were corrected using AutoCTF. Defocused data were collected by defocusing between -2 628 
μm and -3.5 μm every 15 μm, and phase plate data between -0.3 and -0.8 μm with 629 
focusing at every hole.  630 
 631 
Image processing  632 
All data datasets were processed in Relion-352. Micrographs were first corrected for large 633 
movements using MotionCorr253 and a 4 x 4 patch with no grouping. CTF parameters 634 
 were estimated using GTCF54. Autopicking was performed in Relion after creating 635 
references from manually picked particles. The processing procedure is summarized in 636 
Supplementary Figure 4. The resolution was calculated using Gold-Standard 0.143 637 
criterion, resulting in a 4.6 Å map for the defocused dataset and 3.2 Å for the phase plate 638 
dataset. The variation in resolution in the map was calculated using the Relion local 639 
resolution implementation. Box sizes of 220 pixels were used for both the defocused and 640 
phase plate datasets. To ensure that high resolution information was not lost by the high 641 
defocus values used for the former dataset, particles were re-extracted in 400 pixel boxes 642 
and subjected to 3D refinement. No increase in resolution was observed for the larger box 643 
size particles. B-factor plots were calculated using the bfactor_plot.py scripts provided 644 
with Relion. 645 
 646 
Model building and refinement  647 
A model was built into the 3.2 Å map by initially docking the receptor binding domain of 648 
wild type Etx crystal structure (PDB: 1UYJ) and then extending this using Coot. 649 
Refinement of the atomic coordinates was performed using Phenix55 real space refine and 650 
re-iterating the model building-refinement procedure several times. 651 
 652 
Statistics  653 
Data were analyzed using Prism v7 software (GraphPad Software, Inc., La Jolla, CA, 654 
USA). Data are expressed as the mean value ± SEM.  655 
 656 
Data availability  657 
 Data supporting the findings of this manuscript are available from the corresponding 658 
author upon reasonable request.  A reporting summary for this Article is available as a 659 
Supplementary Information file. 660 
The cryo-EM maps of epsilon toxin pore have been deposited to the Electron Microscopy 661 
Data Bank under accession number EMD-4789 and the refined atomic coordinates have 662 
been deposited to the Protein Data Bank under accession number 6RB9. The source data 663 
for Figure 1 and Supplementary Figures 2, 12-15 are provided as a Source Data file.  664 
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 Figure legends 894 
Figure 1 Cytotoxic activity of wild type epsilon toxin towards Super Dome cells  895 
(a) The cytotoxic activity of trypsin-activated recombinant wild type Etx towards Super 896 
Dome cells was determined by measuring the release of LDH from lysed cells. Results 897 
were normalised to the signal from cells treated with DPBS only (0% lysis) and cells 898 
treated with 0.9% (v/v) Triton X-100 (100% lysis). Results are presented as the mean of 899 
triplicate assays, each performed in triplicate (± S.E.M.). (b) Purified Etx pore was 900 
separated by SDS-PAGE and visualized by Coomassie staining. Arrows indicate the 901 
positions of Etx pore (p) and Etx monomer (m). Source data are provided as a Source 902 
Data file. 903 
 904 
Figure 2 Cryo-EM of epsilon toxin pores using the Volta phase plate  905 
(a) Electron micrograph of a typical field of view of isolated Etx pores. Particles that 906 
were included in the final 3D map are highlighted. (b) Characteristic 2D class averages. 907 
Sharpened cryo-EM map of the pore colored by monomer as visualized from the side (c) 908 
and extracellular (d) views. Scale bar corresponds to 50 nm. 909 
 910 
Figure 3 Atomic model of the epsilon toxin pore  911 
Cartoon representation of the heptameric Etx model with height, width and lumen 912 
dimensions indicated (a, b). The monomers are coloured by domain; green - receptor 913 
binding domain, blue - β hairpin domain, yellow - cap domain. (c) Close-up view of the 914 
inner β-barrel and membrane spanning region. Residues identified in previous studies as 915 
important to receptor binding in the RBD, as well as residues forming the aromatic belts, 916 
 are highlighted in stick representation. The approximate boundaries of the lipid bilayer 917 
are coloured light brown. (d) Close-up view of the DBB fold viewed from the membrane 918 
side with interacting residues shown in stick representation. 919 
 920 
Figure 4 Conformational changes accompanying pore formation  921 
Wire representation of Etx monomers in the water-soluble and membrane-inserted state 922 
coloured by domain as in Figure 3 and viewed from different angles (a-c).  The two 923 
models were superimposed by their RBD which remains mostly unchanged during the 924 
transition. The cap domain collapses by 45 Å allowing the pre-insertion strands to get 925 
closer to the membrane and form the inner β-barrel. The heptameric pore is also shown 926 
for context. Curved arrow in (c) illustrates outward movement of the cap domain in the 927 
membrane-inserted form. 928 
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